Dexamethasone added to COVID-19 treatment protocol
It replaces methylprednisolone for managing moderate to severe cases
Author
Study reveals COVID-19 virus can cause collapse of respiratory centre in brain
May infect PreBötzinger complex (PBC), primary centre of the brain that controls respiratory rhythm generation
Umifenovir gets DCGI nod for Phase III clinical trial against COVID-19
CSIR-CDRI has developed the process technology for Umifenovir and licensed the process technology for manufacturing and marketing…
JNU researchers develop new drug molecules to can act against amoebiasis
Entamoeba expresses two crucial enzymes for synthesising cysteine and researchers from JNU have, reportedly, characterised and…
NIPERs should try to establish national-level testing labs for pharma products: Mandaviya
The Minister of State for Chemicals and Fertilizers, at a review meeting with Directors of NIPERs, stated that NIPERs can be…
Modi, Netanyahu discuss India-Israel partnerships to fight COVID-19
Confer on ways to collaborate on research and development efforts in the fields of vaccines, therapeutics and diagnostics, among…
Indian study may develop therapeutics for tongue cancer
Identify a specific microRNA (miRNAs) called ‘miR-155’ that is over-expressed in tongue cancer
CSIR’s anti-cancer drug IIIM-290 goes into clinical trial
The clinical trial aims to assess safety, tolerability and exposure of the compound in humans along with the early efficacy…
NIPER Guwahati and HAL sign MOU for industrial grade 3D antimicrobial face-shields
NIPER-G has designed, developed and validated these face-shields to control the spread of novel coronavirus after analyses of…
CSIR and AIM sign a LoI to foster innovation
The joint initiatives and collaboration will be implemented through the development of Work Plans